Selexipag
NDC 70710-1551, Selexipag, tablet, film coated, from Zydus Pharmaceuticals (USA) Inc..
- Product NDC
- 70710-1551
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214302
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1551 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SELEXIPAG200 ug/1
Pharmacologic classes
Prostacyclin Receptor Agonist [EPC]; Prostacyclin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1551-6 | 70710155106 | 60 TABLET, FILM COATED in 1 BOTTLE (70710-1551-6) |
| 70710-1551-8 | 70710155108 | 140 TABLET, FILM COATED in 1 BOTTLE (70710-1551-8) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c604e181-e336-4194-bf96-f65dd164d461
Use it
Look up 70710-1551 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1551 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1551. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.